Acumen LLC

Acumen LLC, doing business as Medric, is a for-profit limited liability partnership headquartered in Burlingame, California, that delivers healthcare data analytics, research, program evaluation, and technical assistance to federal health agencies as a prime contractor (98% of recent awards) across full-and-open procurements with no set-aside posture. The vendor competes on GSA Schedule, indefinite delivery vehicles, and agency-specific IDIQs serving CMS, the FDA, the NIH, CDC, and HRSA with a $18.09 billion combined potential value across 210 awards in the source dataset.

Acumen's customer concentration is extreme and singular. The Centers for Medicare and Medicaid Services accounts for 130 awards (62% of the total award count) with $15.26 billion in combined potential value—84% of the vendor's total potential-value footprint. The five largest customers by value (CMS, GSA Federal Acquisition Service, HHS Office of the Assistant Secretary for Administration, HRSA, and FDA) cover 99% of combined potential value. Within the CMS account, the vendor operates across multiple indefinite delivery vehicles: the Research, Measurement, Assessment, Design, and Analysis (RMADA) suite of IDIQs, the Measure and Instrument Development and Support (MIDS 2) IDIQ, and the provider enrollment and oversight IDIQ, with recent delivery orders including a $77.3 million data analytics order for CMS payment systems dated September 30, 2026; a $56.9 million delivery order for the Transforming Episode Accountability Model (TEAM) under RMADA 2 dated January 3, 2025; and a $24.4 million Data Modeling and Analysis Contract (DMAC) delivery order dated May 16, 2025. Acumen also holds a newly awarded $3.5 billion RMADA 3 IDIQ (July 9, 2026) providing analytic support for CMS policy development and healthcare data initiatives. The FDA relationship centers on the Biologics Effectiveness and Safety (BEST) Initiative, where Acumen holds a $75 million indefinite delivery contract awarded September 27, 2024, supporting post-market surveillance of biologic products, complemented by task orders valued at $5.45 million and $25.7 million on prior-year BEST vehicles. The NIH National Institute on Aging awarded a $52.9 million GSA Schedule delivery order (September 27, 2021) for linkage, review, and cloud support services across study data, with a recent one-year renewal of $9.2 million dated March 26, 2026.

Acumen holds three major vehicle positions. On the GSA Multiple Award Schedule, the vendor has placed 66 task orders ($684.8 million combined potential value) spanning program evaluation, data analysis, IT professional services, and research roles. In December 2024, GSA added Acumen to the OASIS+ Unrestricted government-wide acquisition contract (no dollar ceiling specified) and awarded a $1.148 billion Federal Supply Schedule contract covering management consulting, IT professional services, and healthcare-focused labor categories. The vendor also sits on the $149 million CDC Vaccine Safety Datalink IDIQ (September 20, 2022) and the $344.7 million HRSA Evaluations and Evidence Building single-award IDIQ (September 26, 2024). Eleven CMS awards operate under the RMADA vehicle family across different generations (RMADA 2, RMADA 3), with 11 task orders carrying $242.7 million in combined potential value.

Activity remains flat year-to-year: four to eight awards annually from 2022 to 2026, with the most recent award dated September 30, 2026. Thirteen awards (combined potential value $346.2 million) reach ultimate completion within the next twenty-four months and face recompete exposure. Recent modifications under Executive Order 14222 (Department of Government Efficiency Cost Efficiency Initiative) have descoped two CMS task orders—the MIDS 2 physician-level cost measure order (February 26, 2025) and the HRSA Evaluations IDIQ ceiling adjustment (February 26, 2025)—signaling potential contraction in near-term volume.

On SCI-reportable federal service contracts above $150,000, Acumen invoiced $322.3 million across FY2022–FY2024: $101.9 million (FY2022), $110.9 million (FY2023), and $109.5 million (FY2024). The SCI dataset shows a stable workforce of 164–169 FTEs annually performing federal services. Government-paid hourly rates (derived from invoiced dollars and contractor hours) range from a 10th percentile of $109.64/hr to a median of $144.83/hr and a 90th percentile of $177.71/hr, reflecting a mix of research analyst, data scientist, senior partner, and technical management labor. Across SCI-reportable prime contracts, subcontractors perform an average of 45% of contractor hours; Acumen names 195 subcontractors across the SCI footprint, signaling a delivery model that blends internal staff and outsourced execution, particularly for specialized analytic and technical roles. The sub-award footprint is minimal: one contract sub-award to Leidos (May 13, 2025) for ITSSC support goods and services, and four federal grant sub-awards to Brown University (August–September 2022) supporting research on Medicare pharmacy data linkage, nursing home electronic medical records, and COVID-19 vaccine monitoring in elderly populations.

Acumen's award portfolio is categorized under Administrative Management and General Management Consulting Services (89 awards), Research and Development in the Social Sciences and Humanities (70 awards), and Other Scientific and Technical Consulting Services (18 awards), reflecting a NAICS footprint centered on analytics, research support, and program evaluation rather than IT commodity delivery. The vendor's 23-year SAM.gov registration tenure (since 2003) positions it as an incumbent across multiple HHS agency vehicles, and the absence of set-aside posture across the entire portfolio indicates the company competes successfully against large and diverse bidders in open procurements anchored by technical capability and past performance in federal healthcare data management.